Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933
Articolo
Data di Pubblicazione:
1990
Citazione:
Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933 / A. Mazzoni, G. Canti. - In: SELECTIVE CANCER THERAPEUTICS. - ISSN 1043-0733. - 6:4(1990), pp. 167-176.
Abstract:
The ability of RO 11-2933 to modulate in vivo Doxorubicin and Cisplatin antitumor activity has been evaluated in sensitive and resistant P388 and L1210 murine leukemias. A reversal of both Doxorubicin or Cisplatin resistance has been observed when P388/Dx or L1210/CP tumor bearing mice received multiple treatments of the antitumor agent plus 30 mg/Kg of RO 11-2933. No modification of Doxorubicin or Cisplatin effect has been observed in sensitive tumors. The results obtained indicate that RO 11-2933 might represent a promising agent for the reversal of multidrug resistance.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Animals; Drug Screening Assays, Antitumor; Drug Interactions; Propylamines; Calcium Channel Blockers; Drug Resistance; Mice; Doxorubicin; Leukemia L1210; Mice, Inbred DBA; Neoplasm Transplantation; Cisplatin; Leukemia P388; Female
Elenco autori:
A. Mazzoni, G. Canti
Link alla scheda completa: